NOT KNOWN FACTS ABOUT AZELAPRAG PEPTIDE

The biotech sought to bear this mechanism out in STRIDES, a mid-stage, randomized, double-blinded and placebo-controlled demo that evaluated the efficacy and protection of azelaprag—with and without having Eli Lilly’s blockbuster incretin procedure tirzepatide—in greater than 200 men and women with being overweight.Apelin receptor agonists ar